UBS AM’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-23,834
| Closed | -$442K | – | 2633 |
|
|
2023
Q3 | $442K | Hold |
23,834
| – | – | ﹤0.01% | 2341 |
|
|
2023
Q2 | $320K | Hold |
23,834
| – | – | ﹤0.01% | 2457 |
|
|
2023
Q1 | $320K | Sell |
23,834
-3,745
| -14% | -$50.3K | ﹤0.01% | 2457 |
|
|
2022
Q4 | $341K | Buy |
27,579
+14,948
| +118% | +$185K | ﹤0.01% | 2306 |
|
|
2022
Q3 | $176K | Sell |
12,631
-10,792
| -46% | -$151K | ﹤0.01% | 2626 |
|
|
2022
Q2 | $323K | Sell |
23,423
-1,686
| -7% | -$23.3K | ﹤0.01% | 2454 |
|
|
2022
Q1 | $409K | Hold |
25,109
| – | – | ﹤0.01% | 2528 |
|
|
2021
Q4 | $409K | Hold |
25,109
| – | – | ﹤0.01% | 2618 |
|
|
2021
Q3 | $373K | Hold |
25,109
| – | – | ﹤0.01% | 2582 |
|
|
2021
Q2 | $501K | Buy |
25,109
+12,478
| +99% | +$249K | ﹤0.01% | 2536 |
|
|
2021
Q1 | $292K | Hold |
12,631
| – | – | ﹤0.01% | 2491 |
|
|
2020
Q4 | $312K | Sell |
12,631
-147,885
| -92% | -$3.65M | ﹤0.01% | 2403 |
|
|
2020
Q3 | $6.65M | Sell |
160,516
-5,750
| -3% | -$238K | ﹤0.01% | 1058 |
|
|
2020
Q2 | $7.97M | Sell |
166,266
-2,243
| -1% | -$107K | ﹤0.01% | 974 |
|
|
2020
Q1 | $10.6M | Sell |
168,509
-14,696
| -8% | -$925K | 0.01% | 848 |
|
|
2019
Q4 | $22.7M | Buy |
183,205
+24,066
| +15% | +$2.98M | 0.01% | 740 |
|
|
2019
Q3 | $10.6M | Buy |
159,139
+2,098
| +1% | +$139K | 0.01% | 936 |
|
|
2019
Q2 | $12.5M | Buy |
157,041
+61,017
| +64% | +$4.86M | 0.01% | 890 |
|
|
2019
Q1 | $10.7M | Buy |
96,024
+2,946
| +3% | +$330K | 0.01% | 912 |
|
|
2018
Q4 | $9.38M | Sell |
93,078
-23,037
| -20% | -$2.32M | 0.01% | 895 |
|
|
2018
Q3 | $14.7M | Buy |
116,115
+105,719
| +1,017% | +$13.4M | 0.01% | 841 |
|
|
2018
Q2 | $872K | Buy |
10,396
+716
| +7% | +$60.1K | ﹤0.01% | 1865 |
|
|
2018
Q1 | $596K | Hold |
9,680
| – | – | ﹤0.01% | 1966 |
|
|
2017
Q4 | $566K | Buy |
9,680
+455
| +5% | +$26.6K | ﹤0.01% | 1929 |
|
|
2017
Q3 | $535K | Sell |
9,225
-142,138
| -94% | -$8.25M | ﹤0.01% | 1922 |
|
|
2017
Q2 | $18.3M | Sell |
151,363
-5,844
| -4% | -$708K | 0.02% | 765 |
|
|
2017
Q1 | $17.8M | Buy |
157,207
+25,607
| +19% | +$2.9M | 0.02% | 754 |
|
|
2016
Q4 | $14.3M | Sell |
131,600
-4,020
| -3% | -$437K | 0.02% | 783 |
|
|
2016
Q3 | $22.3M | Sell |
135,620
-2,497
| -2% | -$411K | 0.02% | 642 |
|
|
2016
Q2 | $19.7M | Sell |
138,117
-4,468
| -3% | -$637K | 0.02% | 682 |
|
|
2016
Q1 | $18.3M | Buy |
142,585
+5,843
| +4% | +$751K | 0.02% | 692 |
|
|
2015
Q4 | $20.4M | Buy |
136,742
+116
| +0.1% | +$17.3K | 0.02% | 663 |
|
|
2015
Q3 | $22.7M | Sell |
136,626
-11,362
| -8% | -$1.88M | 0.03% | 640 |
|
|
2015
Q2 | $35.7M | Buy |
147,988
+19,463
| +15% | +$4.7M | 0.03% | 522 |
|
|
2015
Q1 | $36.2M | Buy |
128,525
+6,100
| +5% | +$1.72M | 0.03% | 513 |
|
|
2014
Q4 | $19.1M | Buy |
122,425
+29,300
| +31% | +$4.57M | 0.02% | 713 |
|
|
2014
Q3 | $22M | Buy |
93,125
+3,925
| +4% | +$929K | 0.02% | 653 |
|
|
2014
Q2 | $21.1M | Buy |
89,200
+7,000
| +9% | +$1.66M | 0.02% | 662 |
|
|
2014
Q1 | $27.1M | Sell |
82,200
-26,300
| -24% | -$8.67M | 0.03% | 568 |
|
|
2013
Q4 | $7.41M | Buy |
+108,500
| New | +$7.41M | 0.01% | 908 |
|